gvtcx

Egg-based Quadrivalent Influenza Vaccine

key details

Statuscomplete
Category (CPV) 33651660
Procedurelimited
OCIDocds-h6vhtk-02a44f

Awards (3)

This procurement was awarded to 3 suppliers. Values shown are per-award; the notice total is ·.

SupplierValueDateStatus
Aventis Pharma Ltd t/a Sanofi · · ·
Aventis Pharma Ltd Trading As Sanofi shared · · ·
Mylan UK Healthcare Limited shared · · ·

description

This procurement is for the supply of egg-based quadrivalent influenza vaccine, suitable for use from age 6 months, to NHSScotland for use in the annual seasonal influenza immunisation programme.

documents

Documents are linked, not mirrored. They are served by the publishing authority and may require registration.

notice history

4 notices published against this procurement.

PublishedTypeRegimeNotice
9 Apr 2021 Voluntary ex-ante transparency (F15) Earlier regulations 007390-2021
29 Apr 2021 Contract award notice (F03) Earlier regulations 009339-2021
5 Apr 2022 Voluntary ex-ante transparency (F15) Earlier regulations 009067-2022
5 May 2022 Contract award notice (F03) Earlier regulations 011597-2022

more from The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Find a Tender. Contact details for named individuals are not reproduced on this site.